Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Genetic Tech Spn ADR
(NQ:
GENE
)
0.9001
+0.0001 (+0.01%)
Streaming Delayed Price
Updated: 3:43 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Genetic Tech Spn ADR
< Previous
1
2
Next >
Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
July 16, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
GeneType to Enter Canadian and New Zealand Markets
July 09, 2024
Genomics-based testing brand expands international presence as pilot influencer campaign fuels sales
From
Genetic Technologies Ltd
Via
GlobeNewswire
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
June 25, 2024
Results from commercial sales of predictive testing across the US and Australia establish clear advantages of geneType Risk Assessment Tests for a more preventive approach in disease management
From
Genetic Technologies Ltd
Via
GlobeNewswire
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
June 21, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Expands Operational Capacity in North America
June 18, 2024
Global leader in personalized predictive genetics launches testing operations for geneType disease risk assessments at US based, world-leading genetic laboratory, Gene by Gene
From
Genetic Technologies Ltd
Via
GlobeNewswire
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
June 05, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
May 29, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
GeneType and Humanise Health host “Know Your Risk” Event
May 23, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
May 06, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Appendix 4C & Quarterly Business Update – March 2024
April 30, 2024
Launching our most comprehensive test and expanding into new global markets
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
April 22, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Announces $2 Million Registered Direct Offering
April 18, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
April 17, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
April 16, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
April 12, 2024
Via
ACCESSWIRE
GTG to pilot GeneType in Breast Screen centers across the U.S.
April 11, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
April 08, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
April 02, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
GTG Global Collaborations and Innovation Update
March 26, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
March 25, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
GTG to launch U.S. Customer Digital Media Sales Campaign
February 28, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Launching our most comprehensive test and expanding into new global markets
January 31, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
January 05, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
December 29, 2023
Via
ACCESSWIRE
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
December 14, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
December 12, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
October 30, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
October 18, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
October 06, 2023
Via
ACCESSWIRE
Genetic Technologies building pathway to profitability
September 27, 2023
Genetic Technologies Ltd (ASX:GTG; NASDAQ:GENE) CEO Simon Morriss tells Proactive the focus over the next 18 years is putting the pathway in place to see the business on track to profitability. GTG...
Via
TheNewswire.com
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.